Thousands of people living with advanced #prostatecancer will have access to a life-extending new treatment that can be taken at home from today. Find out more about talazoparib: https://t.co/sC9pvUv8sS

Thousands of people set to benefit from a new lung cancer treatment that can be taken before and after surgery. Find out more about nivolumab: https://t.co/lbHjeMv389

We’re excited to share that @NICEComms has approved a new targeted treatment for Chronic Obstructive Pulmonary Disease (COPD) which could ‘transform the lives’ of almost 30,000 people with the lung condition in England. Dupilumab comes in pre-filled pens that patients take home

Our CEO, Lawrence Tallon, will be speaking at #NICEConf26, focusing on MHRA–NICE collaboration, integrated advice and approval pathways, and the role of partnership in shaping the future of regulation. 🔗 Register: https://t.co/m7hPYQ9ZUR ℹ️ https://t.co/wcMZEYfy9w @NICEComms

Just over 1,100 people with a form of advanced lung cancer are set to benefit from a new first-line treatment option today. Read more about our final guidance on amivantamab with lazertinib: https://t.co/yU3KXkiJDJ

We welcome approval of a new treatment for Lupus Nephritis in England & Wales. This CD20-targeting monoclonal antibody is less likely to cause reactions & has been shown to reduce kidney decline. Encouraging progress for people with lupus @NICEComms https://t.co/5Q4K2eTWpt

“[#Obinutuzumab (Gazyvaro)] has been approved for #NHS use, offering new hope to the nearly 12,000 people in England living with #LupusNephritis.”: https://t.co/nhpf59LQW6 from @NICEComms #lupus #rheumatology

2023: BPNA 21 replaced 2025: @NHS acknowledge #PansPandasHour 2026: @NICEComms works with the GDG on UK guidelines. Surely now clinicians allowing children to be lost to these devastating conditions must face scrutiny. @jamiemroberton @anne_delaney @claudiahammond @thismorning

Helen Knight, our director of medicines evaluation said obinutuzumab with immunosuppressants had been shown to improve people’s quality of life⬇️

Lee Waters MS discussed in @SeneddWales the need for a national plan to improve #TouretteSyndrome services View here https://t.co/u3ojJ1Uf8C Members were in agreement - theres a lack of consistent specialist support across #Wales & the lack of @nicecomms further compounds this

@meadowcopse @onein300 @BVirgo1 @burrow_geoff @MHRAgovuk @NICEComms @mndassoc @GOVUK @wesstreeting @ClaireRyanBBC @sallynugent @edslater Not sure, but it definitely needs addressing, allowing certain people torfesen and others namely 18 not allowed needs to be addressed, its totally unethical to say no your not allowed a drug that in some not all cases can enhance your life

@NICEComms “One important addition to this section is a reminder “that every woman's experience of pain is unique and may be expressed in different ways.” “NICE guidelines for labour pain emphasize personalized, woman-centered care, encouraging mobility, relaxation, and various

We have recommended a twice-yearly infusion that offers hope of normal kidney function for thousands living with lupus. Find out more about obinutuzumab: https://t.co/VK0gnnMKAK

Today’s recommendation has also been welcomed by @ProstateUK, who said this is an exciting treatment that provides a real lifeline and allows men to spend more precious time with their loved ones.

Have your say on how NICE manages ongoing evaluations ahead of proposed changes to cost-effectiveness thresholds for technology appraisals: https://t.co/hSf4icz5wK

At-home treatment recommended for some types of ovarian cancer. Niraparib, an oral maintenance therapy, can be prescribed following response to first-line chemotherapy. View the guidance: https://t.co/ub3UJEBXqn

@JANEDART5 @NICEComms This is available for you to read here:

@MHRAgovuk @NICEComms @MHRAgovuk Looking forward to hopefully hearing about the collaboration and approval of #DCVax-L by $NWBO.

Welcomed news for many patients who can benefit from biologics in #COPD @UKCPAResp